Zhaohui Chen

Quest Diagnostics (United States)

Papers

1

Total Citations

57

H-Index

1

About

Zhaohui Chen is a leading biochemist whose research focuses on advancing mass spectrometry-based methodologies for clinical and biomedical applications, with a particular emphasis on peptide and protein analysis. Chen’s most impactful contribution is the development of a high-throughput mass spectrometry assay that simultaneously measures intact insulin and C-peptide, a breakthrough published in 2016 that has garnered 57 citations. This work addresses a critical need in diabetes research and clinical diagnostics, enabling more efficient and accurate monitoring of insulin secretion and beta-cell function. By streamlining the quantification of these key biomarkers, Chen’s assay has improved the feasibility of large-scale studies and routine clinical testing, reducing sample preparation time and enhancing throughput without compromising sensitivity. The method’s adoption by other laboratories underscores its practical significance, offering a robust tool for both metabolic research and patient care. Chen’s achievements highlight a commitment to translating complex analytical chemistry into accessible, high-impact solutions, making their work essential reading for researchers in proteomics, endocrinology, and clinical chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide
57 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago